{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:37:57Z","timestamp":1792085877678,"version":"4.4.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Science and Technology Development Funds","award":["22QA1411400"],"award-info":[{"award-number":["22QA1411400"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81973289"],"award-info":[{"award-number":["81973289"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-026-07234-y","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:15:34Z","timestamp":1772525734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Classifying drug-related problems of neurodegenerative diseases in the physician-pharmacist joint clinic of neurology: an application of the PCNE method"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuanjun","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runjuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meina","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxing","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"7234_CR1","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/mds.29386","volume":"38","author":"R Zeng","year":"2023","unstructured":"Zeng R, Wang J, Zheng C, Jiang R, Tong S, Wu H, et al. Lack of Causal Associations of Inflammatory Bowel Disease with Parkinson\u2019s Disease and Other Neurodegenerative Disorders. Mov Disord Off J Mov Disord Soc. 2023;38:1082\u20138. https:\/\/doi.org\/10.1002\/mds.29386.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"7234_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000525639","volume":"56","author":"G Logroscino","year":"2022","unstructured":"Logroscino G, Urso D, Savica R. Descriptive Epidemiology of Neurodegenerative Diseases: What Are the Critical Questions? Neuroepidemiology. 2022;56:309\u201318. https:\/\/doi.org\/10.1159\/000525639.","journal-title":"Neuroepidemiology"},{"key":"7234_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1001\/jamaneurol.2024.0586","volume":"81","author":"J Cummings","year":"2024","unstructured":"Cummings J, Lanctot K, Grossberg G, Ballard C. Progress in Pharmacologic Management of Neuropsychiatric Syndromes in Neurodegenerative Disorders: A Review. JAMA Neurol. 2024;81:645\u201353. https:\/\/doi.org\/10.1001\/jamaneurol.2024.0586.","journal-title":"JAMA Neurol"},{"key":"7234_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1212\/WNL.0000000000207193","volume":"101","author":"D Alcolea","year":"2023","unstructured":"Alcolea D, Beeri MS, Rojas JC, Gardner RC, Lle\u00f3 A. Blood Biomarkers in Neurodegenerative Diseases: Implications for the Clinical Neurologist. Neurology. 2023;101:172\u201380. https:\/\/doi.org\/10.1212\/WNL.0000000000207193.","journal-title":"Neurology"},{"key":"7234_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/978-3-319-57193-5_20","volume":"15","author":"A Jeromin","year":"2017","unstructured":"Jeromin A, Bowser R. Biomarkers in Neurodegenerative Diseases. Adv Neurobiol. 2017;15:491\u2013528. https:\/\/doi.org\/10.1007\/978-3-319-57193-5_20.","journal-title":"Adv Neurobiol"},{"key":"7234_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"GBD 2021 Nervous System Disorders Collaborators","year":"2024","unstructured":"GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23:344\u201381. https:\/\/doi.org\/10.1016\/S1474-4422(24)00038-3.","journal-title":"Lancet Neurol"},{"key":"7234_CR7","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.sapharm.2023.02.015","volume":"19","author":"QN Xue Qin","year":"2023","unstructured":"Xue Qin QN, Ming LC, Abd Wahab MS, Tan CS, Yuda A, Hermansyah A. Drug-related problems among older people with dementia: A systematic review. Res Soc Adm Pharm RSAP. 2023;19:873\u201381. https:\/\/doi.org\/10.1016\/j.sapharm.2023.02.015.","journal-title":"Res Soc Adm Pharm RSAP"},{"key":"7234_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2013.01.012","volume":"10","author":"J Jia","year":"2014","unstructured":"Jia J, Wang F, Wei C, Zhou A, Jia X, Li F, et al. The prevalence of dementia in urban and rural areas of China. Alzheimers Dement J Alzheimers Assoc. 2014;10:1\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2013.01.012.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"7234_CR9","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 2016;15:1257\u201372. https:\/\/doi.org\/10.1016\/S1474-4422(16)30230-7.","journal-title":"Lancet Neurol"},{"key":"7234_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C. The epidemiology of Parkinson\u2019s disease. Lancet Lond Engl. 2024;403:283\u201392. https:\/\/doi.org\/10.1016\/S0140-6736(23)01419-8.","journal-title":"Lancet Lond Engl"},{"key":"7234_CR11","doi-asserted-by":"publisher","unstructured":"Tysnes O-B, Storstein A. Epidemiology of Parkinson\u2019s disease. J Neural Transm Vienna Austria. 1996. 2017;124:901\u20135. https:\/\/doi.org\/10.1007\/s00702-017-1686-y.","DOI":"10.1007\/s00702-017-1686-y"},{"key":"7234_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000527372","volume":"57","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Zhu Z, Zhou C, Cao L, Zhao G. Burden of Parkinson Disease in China, 1990\u20132019: Findings from the 2019 Global Burden of Disease Study. Neuroepidemiology. 2023;57:51\u201364. https:\/\/doi.org\/10.1159\/000527372.","journal-title":"Neuroepidemiology"},{"key":"7234_CR13","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3390\/jcm13061638","volume":"13","author":"P Pramotesiri","year":"2024","unstructured":"Pramotesiri P, Putthipokin K, Ruangritchankul S. Drug Related Problems among Older Inpatients at a Tertiary Care Setting. J Clin Med. 2024;13:1638. https:\/\/doi.org\/10.3390\/jcm13061638.","journal-title":"J Clin Med"},{"key":"7234_CR14","doi-asserted-by":"publisher","first-page":"205031212211358","DOI":"10.1177\/20503121221135874","volume":"10","author":"SB Dagnew","year":"2022","unstructured":"Dagnew SB, Tadesse TY, Zeleke MM, Yiblet TG, Addis GT, Mekonnen GB, et al. Drug-drug interactions among hospitalized elderly in patients at medical wards of Northwest Ethiopia\u2019s Comprehensive Specialized Hospitals: A multicenter observational study. SAGE Open Med. 2022;10:20503121221135874. https:\/\/doi.org\/10.1177\/20503121221135874.","journal-title":"SAGE Open Med"},{"key":"7234_CR15","doi-asserted-by":"publisher","first-page":"8830606","DOI":"10.1155\/2021\/8830606","volume":"2021","author":"L Meng","year":"2021","unstructured":"Meng L, Qu C, Qin X, Huang H, Hu Y, Qiu F, et al. Drug-Related Problems among Hospitalized Surgical Elderly Patients in China. BioMed Res Int. 2021;2021:8830606. https:\/\/doi.org\/10.1155\/2021\/8830606.","journal-title":"BioMed Res Int"},{"key":"7234_CR16","doi-asserted-by":"publisher","first-page":"205031212198962","DOI":"10.1177\/2050312121989625","volume":"9","author":"F Bekele","year":"2021","unstructured":"Bekele F, Fekadu G, Bekele K, Dugassa D, Sori J. Drug-related problems among patients with infectious disease admitted to medical wards of Wollega University Referral Hospital: Prospective observational study. SAGE Open Med. 2021;9:2050312121989625. https:\/\/doi.org\/10.1177\/2050312121989625.","journal-title":"SAGE Open Med"},{"key":"7234_CR17","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.3233\/JAD-170371","volume":"61","author":"M Fran\u00e7ois","year":"2018","unstructured":"Fran\u00e7ois M, Sicsic J, Pelletier Fleury N. Drugs for Dementia and Excess of Hospitalization: A Longitudinal French Study. J Alzheimers Dis JAD. 2018;61:1627\u201337. https:\/\/doi.org\/10.3233\/JAD-170371.","journal-title":"J Alzheimers Dis JAD"},{"key":"7234_CR18","doi-asserted-by":"publisher","first-page":"e0236830","DOI":"10.1371\/journal.pone.0236830","volume":"15","author":"S Ruangritchankul","year":"2020","unstructured":"Ruangritchankul S, Peel NM, Hanjani LS, Gray LC. Drug related problems in older adults living with dementia. PLoS ONE. 2020;15:e0236830. https:\/\/doi.org\/10.1371\/journal.pone.0236830.","journal-title":"PLoS ONE"},{"key":"7234_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/539179a","volume":"539","author":"M-T Heemels","year":"2016","unstructured":"Heemels M-T, Neurodegenerative diseases. Nature. 2016;539:179. https:\/\/doi.org\/10.1038\/539179a.","journal-title":"Nature"},{"key":"7234_CR20","unstructured":"Checkoway H, Lundin JI, Kelada SN. Neurodegenerative diseases. IARC Sci Publ. 2011;163:407\u201319."},{"key":"7234_CR21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1186\/s12877-023-04557-y","volume":"23","author":"S Zhang","year":"2023","unstructured":"Zhang S, Zhang G-B, Huang P, Ren Y, Lin B, Shao Y-F, et al. Drug-related problems in hospitalized patients with chronic kidney diseases and clinical pharmacist interventions. BMC Geriatr. 2023;23:849. https:\/\/doi.org\/10.1186\/s12877-023-04557-y.","journal-title":"BMC Geriatr"},{"key":"7234_CR22","first-page":"856","volume":"36","author":"M Messerli","year":"2014","unstructured":"Messerli M, Griese N, Hersberger KE. Development of the PCNE standards for medication reviews. Int J Clin Pharm. 2014;36:856\u20137.","journal-title":"Int J Clin Pharm"},{"key":"7234_CR23","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s11096-014-9933-x","volume":"36","author":"SS Allemann","year":"2014","unstructured":"Allemann SS, van Mil JWF, Botermann L, Berger KU, Griese N, Hersberger KE. Evolution of pharmaceutical care definitions: the PCNE definition 2013. Int J Clin Pharm. 2014;36:851\u2013851.","journal-title":"Int J Clin Pharm"},{"key":"7234_CR24","first-page":"786","volume":"43","author":"M Odalovic","year":"2021","unstructured":"Odalovic M, Miljkovic B, Kovacevic SV, Vojinovic JS, Simisic M, Miljkovic N. The PCNE drug-related problem classification V 9.0: translation and validation by Serbian pharmacists. Int J Clin Pharm. 2021;43:786\u20137.","journal-title":"Int J Clin Pharm"},{"key":"7234_CR25","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3390\/healthcare10040751","volume":"10","author":"KT Nguyen","year":"2022","unstructured":"Nguyen KT, Le VTT, Nguyen TH, Pham ST, Nguyen PM, Taxis K, et al. Effect of Pharmacist-Led Interventions on Physicians\u2019 Prescribing for Pediatric Outpatients. Healthc Basel Switz. 2022;10:751. https:\/\/doi.org\/10.3390\/healthcare10040751.","journal-title":"Healthc Basel Switz"},{"key":"7234_CR26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s11096-017-0585-5","volume":"40","author":"N Abunahlah","year":"2018","unstructured":"Abunahlah N, Elawaisi A, Velibeyoglu FM, Sancar M. Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey. Int J Clin Pharm. 2018;40:360\u20137. https:\/\/doi.org\/10.1007\/s11096-017-0585-5.","journal-title":"Int J Clin Pharm"},{"key":"7234_CR27","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/ejhpharm-2020-002356","volume":"29","author":"H Liu","year":"2022","unstructured":"Liu H, Zhong Y, Zeng Z, Bi W, Zhong H, Xue L, et al. Drug-related problems in hospitalised Parkinson\u2019s disease patients in China. Eur J Hosp Pharm. 2022;29:308\u201312. https:\/\/doi.org\/10.1136\/ejhpharm-2020-002356.","journal-title":"Eur J Hosp Pharm"},{"key":"7234_CR28","first-page":"526","volume":"45","author":"M Nedeljkovic","year":"2023","unstructured":"Nedeljkovic M, Odalovic M, Jocic D, Tadic I. PCNE Classification for Drug-Related Problems V9.00-a tool for better provision of pharmaceutical care services for patients with diabetes. Int J Clin Pharm. 2023;45:526\u2013526.","journal-title":"Int J Clin Pharm"},{"key":"7234_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1055\/s-0031-1271426","volume":"137","author":"R Schneider","year":"2012","unstructured":"Schneider R, Ranft D, Heinitz K, Uhlmann D, Hauss J, Frontini R, et al. Pharmaceutical Care in a Visceral Surgical Ward. Zentralbl Chir. 2012;137:173\u20139. https:\/\/doi.org\/10.1055\/s-0031-1271426.","journal-title":"Zentralbl Chir"},{"key":"7234_CR30","first-page":"814","volume":"44","author":"K Romero Viamonte","year":"2022","unstructured":"Romero Viamonte K, Salvent Tames A, Teixeira-da-Silva P, Rojo Manteca MV, Martin Suarez A. Use of the PCNE classification to analyze DRPs associated with the use of antibiotics in caesarean sections. Int J Clin Pharm. 2022;44:814\u2013814.","journal-title":"Int J Clin Pharm"},{"key":"7234_CR31","doi-asserted-by":"publisher","first-page":"874948","DOI":"10.3389\/fphar.2022.874948","volume":"13","author":"X-F Ni","year":"2022","unstructured":"Ni X-F, Yang C-S, Zeng L-N, Li H-L, Diao S, Li D-Y, et al. Drug-Related Problems of Children With Chronic Diseases in a Chinese Primary Health Care Institution: A Cross-Sectional Study. Front Pharmacol. 2022;13:874948. https:\/\/doi.org\/10.3389\/fphar.2022.874948.","journal-title":"Front Pharmacol"},{"key":"7234_CR32","doi-asserted-by":"publisher","first-page":"205031212110097","DOI":"10.1177\/20503121211009728","volume":"9","author":"Y Ayele","year":"2021","unstructured":"Ayele Y, Tesfaye ZT. Drug-related problems in Ethiopian public healthcare settings: Systematic review and meta-analysis. SAGE Open Med. 2021;9:20503121211009728. https:\/\/doi.org\/10.1177\/20503121211009728.","journal-title":"SAGE Open Med"},{"key":"7234_CR33","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s11096-020-01128-8","volume":"43","author":"Z Ma","year":"2021","unstructured":"Ma Z, Sun S, Zhang C, Yuan X, Chen Q, Wu J, et al. Characteristics of drug-related problems and pharmacists\u2019 interventions in a geriatric unit in China. Int J Clin Pharm. 2021;43:270\u20134. https:\/\/doi.org\/10.1007\/s11096-020-01128-8.","journal-title":"Int J Clin Pharm"},{"key":"7234_CR34","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/mds.26744","volume":"31","author":"ER Dorsey","year":"2016","unstructured":"Dorsey ER, Vlaanderen FP, Engelen LJLPG, Kieburtz K, Zhu W, Biglan KM, et al. Moving Parkinson care to the home. Mov Disord. 2016;31:1258\u201362. https:\/\/doi.org\/10.1002\/mds.26744.","journal-title":"Mov Disord"},{"key":"7234_CR35","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1177\/0269216316669922","volume":"31","author":"S Fox","year":"2017","unstructured":"Fox S, Cashell A, Kernohan WG, Lynch M, McGlade C, O\u2019Brien T, et al. Palliative care for Parkinson\u2019s disease: Patient and carer\u2019s perspectives explored through qualitative interview. Palliat Med. 2017;31:634\u201341. https:\/\/doi.org\/10.1177\/0269216316669922.","journal-title":"Palliat Med"},{"key":"7234_CR36","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/bs.irn.2017.02.017","volume-title":"PARKINSON\u2019S DISEASE","author":"R Bouca-Machado","year":"2017","unstructured":"Bouca-Machado R, Titova N, Chaudhuri KR, Bloem BR, Ferreira JJ. Palliative Care for Patients and Families With Parkinson\u2019s Disease. In: Bhatia KP, Chaudhuri KR, Stamelou M, editors. PARKINSON\u2019S DISEASE. San Diego: Elsevier Academic Press Inc; 2017. pp. 475\u2013509. https:\/\/doi.org\/10.1016\/bs.irn.2017.02.017."},{"key":"7234_CR37","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/FCH.0000000000000159","volume":"40","author":"KA Schuller","year":"2017","unstructured":"Schuller KA, Vaughan B, Wright I. Models of Care Delivery for Patients With Parkinson Disease Living in Rural Areas. Fam COMMUNITY Health. 2017;40:324\u201330. https:\/\/doi.org\/10.1097\/FCH.0000000000000159.","journal-title":"Fam COMMUNITY Health"},{"key":"7234_CR38","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1248\/bpb.b18-00134","volume":"41","author":"Y Tega","year":"2018","unstructured":"Tega Y, Yamazaki Y, Akanuma S-I, Kubo Y, Hosoya K-I. Impact of Nicotine Transport across the Blood-Brain Barrier: Carrier-Mediated Transport of Nicotine and Interaction with Central Nervous System Drugs. Biol Pharm Bull. 2018;41:1330\u20136. https:\/\/doi.org\/10.1248\/bpb.b18-00134.","journal-title":"Biol Pharm Bull"},{"key":"7234_CR39","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrn3042","volume":"12","author":"AJ Heinz","year":"2011","unstructured":"Heinz AJ, Beck A, Meyer-Lindenberg A, Sterzer P, Heinz A. Cognitive and neurobiological mechanisms of alcohol-related aggression. Nat Rev Neurosci. 2011;12:400\u201313. https:\/\/doi.org\/10.1038\/nrn3042.","journal-title":"Nat Rev Neurosci"},{"key":"7234_CR40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000534620","volume":"82","author":"G Spitta","year":"2023","unstructured":"Spitta G, Garbusow M, Buchert R, Heinz A. Dopamine and Alcohol: A Review of in vivo PET and SPECT Studies. Neuropsychobiology. 2023;82:319\u201345. https:\/\/doi.org\/10.1159\/000534620.","journal-title":"Neuropsychobiology"},{"key":"7234_CR41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/bs.irn.2024.02.003","volume":"175","author":"B S\u00f6derpalm","year":"2024","unstructured":"S\u00f6derpalm B, Ericson M. Alcohol and the dopamine system. Int Rev Neurobiol. 2024;175:21\u201373. https:\/\/doi.org\/10.1016\/bs.irn.2024.02.003.","journal-title":"Int Rev Neurobiol"},{"key":"7234_CR42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cnur.2017.04.007","volume":"52","author":"J Kim","year":"2017","unstructured":"Kim J, Parish AL. Polypharmacy and Medication Management in Older Adults. Nurs Clin North Am. 2017;52:457\u201368. https:\/\/doi.org\/10.1016\/j.cnur.2017.04.007.","journal-title":"Nurs Clin North Am"},{"key":"7234_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3928\/0098-9134-20050401-09","volume":"31","author":"LC Curry","year":"2005","unstructured":"Curry LC, Walker C, Hogstel MO, Burns P. Teaching older adults to self-manage medications: preventing adverse drug reactions. J Gerontol Nurs. 2005;31:32\u201342. https:\/\/doi.org\/10.3928\/0098-9134-20050401-09.","journal-title":"J Gerontol Nurs"},{"key":"7234_CR44","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"MT Hayes","year":"2019","unstructured":"Hayes MT. Parkinson\u2019s Disease and Parkinsonism. Am J Med. 2019;132:802\u20137. https:\/\/doi.org\/10.1016\/j.amjmed.2019.03.001.","journal-title":"Am J Med"},{"key":"7234_CR45","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.amjmed.2018.01.022","volume":"131","author":"SA Gale","year":"2018","unstructured":"Gale SA, Acar D, Daffner KR, Dementia. Am J Med. 2018;131:1161\u20139. https:\/\/doi.org\/10.1016\/j.amjmed.2018.01.022.","journal-title":"Am J Med"},{"key":"7234_CR46","doi-asserted-by":"publisher","first-page":"119129","DOI":"10.1016\/j.lfs.2021.119129","volume":"276","author":"ES Thoe","year":"2021","unstructured":"Thoe ES, Fauzi A, Tang YQ, Chamyuang S, Chia AYY. A review on advances of treatment modalities for Alzheimer?s disease. LIFE Sci. 2021;276:119129. https:\/\/doi.org\/10.1016\/j.lfs.2021.119129.","journal-title":"LIFE Sci"},{"key":"7234_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino R, Schapira AHV. Parkinson disease. Eur J Neurol. 2020;27:27\u201342. https:\/\/doi.org\/10.1111\/ene.14108.","journal-title":"Eur J Neurol"},{"key":"7234_CR48","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s40265-023-01938-w","volume":"83","author":"JL Cummings","year":"2023","unstructured":"Cummings JL, Osse AML, Kinney JW. Alzheimer\u2019s Disease: Novel Targets and Investigational Drugs for Disease Modification. Drugs. 2023;83:1387\u2013408. https:\/\/doi.org\/10.1007\/s40265-023-01938-w.","journal-title":"Drugs"},{"key":"7234_CR49","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and Treatment of Parkinson Disease: A Review. JAMA. 2020;323:548\u201360. https:\/\/doi.org\/10.1001\/jama.2019.22360.","journal-title":"JAMA"},{"key":"7234_CR50","doi-asserted-by":"publisher","first-page":"119129","DOI":"10.1016\/j.lfs.2021.119129","volume":"276","author":"E Se Thoe","year":"2021","unstructured":"Se Thoe E, Fauzi A, Tang YQ, Chamyuang S, Chia AYY. A review on advances of treatment modalities for Alzheimer\u2019s disease. Life Sci. 2021;276:119129. https:\/\/doi.org\/10.1016\/j.lfs.2021.119129.","journal-title":"Life Sci"},{"key":"7234_CR51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/ijms20020381","volume":"20","author":"KH Wong","year":"2019","unstructured":"Wong KH, Riaz MK, Xie Y, Zhang X, Liu Q, Chen H, et al. Review of Current Strategies for Delivering Alzheimer\u2019s Disease Drugs across the Blood-Brain Barrier. Int J Mol Sci. 2019;20:381. https:\/\/doi.org\/10.3390\/ijms20020381.","journal-title":"Int J Mol Sci"},{"key":"7234_CR52","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s40264-021-01099-3","volume":"44","author":"WS Alruqayb","year":"2021","unstructured":"Alruqayb WS, Price MJ, Paudyal V, Cox AR. Drug-Related Problems in Hospitalised Patients with Chronic Kidney Disease: A Systematic Review. Drug Saf. 2021;44:1041\u201358. https:\/\/doi.org\/10.1007\/s40264-021-01099-3.","journal-title":"Drug Saf"},{"key":"7234_CR53","volume-title":"Parkinson\u2019s Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care","author":"National Collaborating Centre for Chronic Conditions (UK)","year":"2006","unstructured":"National Collaborating Centre for Chronic Conditions (UK). Parkinson\u2019s Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care. London: Royal College of Physicians (UK); 2006."},{"key":"7234_CR54","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S2215-0366(17)30015-9","volume":"4","author":"CJ Harmer","year":"2017","unstructured":"Harmer CJ, Duman RS, Cowen PJ. How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry. 2017;4:409\u201318. https:\/\/doi.org\/10.1016\/S2215-0366(17)30015-9.","journal-title":"Lancet Psychiatry"},{"key":"7234_CR55","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/j.1360-0443.1994.tb03743.x","volume":"89","author":"H P\u00e9tursson","year":"1994","unstructured":"P\u00e9tursson H. The benzodiazepine withdrawal syndrome. Addiction. 1994;89:1455\u20139. https:\/\/doi.org\/10.1111\/j.1360-0443.1994.tb03743.x.","journal-title":"Addiction"},{"key":"7234_CR56","doi-asserted-by":"publisher","unstructured":"Sj\u00f6qvist F, Psychotropic. Drugs (2) interaction between Monoamine Oxidase (MAO) inhibitors and other Substances. Proc R Soc Med. 1965;58:967\u201378. https:\/\/doi.org\/10.1177\/003591576505811P206.","DOI":"10.1177\/003591576505811P206"},{"key":"7234_CR57","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41531-023-00589-8","volume":"9","author":"W Sako","year":"2023","unstructured":"Sako W, Kogo Y, Koebis M, Kita Y, Yamakage H, Ishida T, et al. Comparative efficacy and safety of adjunctive drugs to levodopa for fluctuating Parkinson\u2019s disease - network meta-analysis. NPJ Park Dis. 2023;9:143. https:\/\/doi.org\/10.1038\/s41531-023-00589-8.","journal-title":"NPJ Park Dis"},{"key":"7234_CR58","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/s0197-0186(01)00118-8","volume":"40","author":"P Casellas","year":"2002","unstructured":"Casellas P, Galiegue S, Basile AS. Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int. 2002;40:475\u201386. https:\/\/doi.org\/10.1016\/s0197-0186(01)00118-8.","journal-title":"Neurochem Int"},{"key":"7234_CR59","doi-asserted-by":"publisher","unstructured":"Hamed SA, Hadad AFE. The effect of anticholinergic drugs on cognition of patients with Parkinson\u2019s disease: a cohort study from the Egyptian population. Expert Rev Clin Pharmacol. 2024;1\u201311. https:\/\/doi.org\/10.1080\/17512433.2024.2359955.","DOI":"10.1080\/17512433.2024.2359955"},{"key":"7234_CR60","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/2045125314553611","volume":"4","author":"JE Desmarais","year":"2014","unstructured":"Desmarais JE, Beauclair L, Annable L, B\u00e9langer M-C, Kolivakis TT, Margolese HC. Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia. Ther Adv Psychopharmacol. 2014;4:257\u201367. https:\/\/doi.org\/10.1177\/2045125314553611.","journal-title":"Ther Adv Psychopharmacol"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-026-07234-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07234-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07234-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:26:45Z","timestamp":1775647605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12877-026-07234-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7234"],"URL":"https:\/\/doi.org\/10.1186\/s12877-026-07234-y","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"9 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All intervention processes in this study were approved by Shanghai General Hospital Institutional Review Board (yuanlunkuai[2023]240). The patient\u2019s participation is completely voluntary. Each participant or their legal guardian is required to sign a written informed consent form prior to data collection and pharmacist intervention. All methods are carried out in accordance with relevant guidelines and regulations. The right of participants not to participate is respected. Strictly protect the confidentiality and data information of patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"475"}}